Lantern Pharma Inc. (LTRN) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$17.12M | +17.6% |
| 2024 | -$20.78M | -30.2% |
| 2023 | -$15.96M | -11.9% |
| 2022 | -$14.26M | -15.3% |
| 2021 | -$12.36M | -109.3% |
| 2020 | -$5.91M | -143.3% |
| 2019 | -$2.43M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$17.12M | +17.6% |
| 2024 | -$20.78M | -30.2% |
| 2023 | -$15.96M | -11.9% |
| 2022 | -$14.26M | -15.3% |
| 2021 | -$12.36M | -109.3% |
| 2020 | -$5.91M | -143.3% |
| 2019 | -$2.43M | — |